Vivos Therapeutics, Inc. specializes in innovative solutions for the treatment of obstructive sleep apnea (OSA) through its proprietary Vivos Method. This method utilizes noninvasive oral medical devices that have received FDA 510(k) clearance to address mild, moderate, and severe cases of OSA in adults. The Vivos Method focuses on reshaping and expanding the oral cavity to alleviate anatomical issues that contribute to airway obstruction during sleep. By employing a multidisciplinary approach, Vivos integrates the expertise of trained dentists and medical professionals to provide a comprehensive treatment plan that not only targets OSA but also addresses related dental and health concerns.

The technology behind Vivos' treatment is rooted in the understanding that many cases of OSA stem from underdeveloped jaws and oral structures, which can lead to a constricted airway. By correcting these developmental issues, Vivos aims to enhance airflow and improve overall sleep quality. Clinical studies indicate that patients undergoing treatment with Vivos devices experience significant improvements, with many achieving results in an average treatment time of about 12 months. This approach not only offers a potential alternative to traditional CPAP therapy but also emphasizes the importance of addressing the underlying anatomical causes of sleep disorders for long-term health benefits.

United States

Vivos is a Massachusetts-based medical technology firm that researches and develops oral therapies for the treatment of dentofacial abnormalities, and sleep apnea disorders.

Vivos Therapeutics, Inc.

Company Details